Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3). - Wikidata - awgldk - TriplyDB

Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3).

Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3).

http://www.wikidata.org/entity/Q33999649

about

The rise of food allergy: Environmental factors and emerging treatments Update on Early Nutrition and Food Allergy in Children Recent advances in immunotherapy and vaccine development for peanut allergy Innate and adaptive dendritic cell responses to immunotherapy Basic science for the clinician: Mechanisms of sublingual and subcutaneous immunotherapy.Analysis of cytokine production by peanut-reactive T cells identifies residual Th2 effectors in highly allergic children who received peanut oral immunotherapy.Epigenetics and development of food allergy (FA) in early childhood.A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy.Cord blood T cell subpopulations and associations with maternal cadmium and arsenic exposures.Regulatory T cells and their roles in immune dysregulation and allergy.Mechanisms of allergic disease - environmental and genetic determinants for the development of allergy.Suppression of the immunologic response to peanut during immunotherapy is often transient.The role of gene-environment interactions in the development of food allergy.Orally-Induced Intestinal CD4+ CD25+ FoxP3+ Treg Controlled Undesired Responses towards Oral Antigens and Effectively Dampened Food Allergic Reactions.Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapy.Molecular and cellular mechanisms of food allergy and food tolerance.Naturally occurring tolerance acquisition to foods in previously allergic children is characterized by antigen specificity and associated with increased subsets of regulatory T cells.Improvement of Therapeutic Efficacy of Oral Immunotherapy in Combination with Regulatory T Cell-Inducer Kakkonto in a Murine Food Allergy Model Critical role of intestinal interleukin-4 modulating regulatory T cells for desensitization, tolerance, and inflammation of food allergy.Data-driven programmatic approach to analysis of basophil activation tests.Single B-cell deconvolution of peanut-specific antibody responses in allergic patients Successful immunotherapy induces previously unidentified allergen-specific CD4+ T-cell subsets.Diagnosis, management, and investigational therapies for food allergies.Toward precision medicine and health: Opportunities and challenges in allergic diseases Sublingual (SLIT) versus oral immunotherapy (OIT) for food allergy The Role of Skin Barrier in the Pathogenesis of Food Allergy Regulatory T Cell Induced by Poria cocos Bark Exert Therapeutic Effects in Murine Models of Atopic Dermatitis and Food Allergy.Induced regulatory T cells in allograft tolerance via transient mixed chimerism.Food allergy: immune mechanisms, diagnosis and immunotherapy Oral immunotherapy for food allergy: mechanisms and role in management.Immune mechanisms of sublingual immunotherapy.Peanut immunotherapy.The contribution of biotechnology toward progress in diagnosis, management, and treatment of allergic diseases.Oral immunotherapy for the treatment of food allergy.The evolution of allergen and non-specific immunotherapy: past achievements, current applications and future outlook.Developing therapies for peanut allergy.The future of biologics: applications for food allergy.Current developments for improving efficacy of allergy vaccines.Is clinical tolerance possible after allergen immunotherapy?An Examination of Clinical and Immunologic Outcomes in Food Allergen Immunotherapy by Route of Administration.

P2860

Q26744294-E7CA1959-B71D-4C0C-B543-6406BEED2294 Q26753181-3F1E93AA-A1EF-4F34-8C89-D64F750CF16F Q26796442-CEE576D5-2E56-43DF-A9C6-4CF6119E3D8B Q28081972-B10161CB-F0E6-4CF4-BE60-2F5FC0CC1E79 Q30276174-1F8452EE-16E4-450E-826B-DD845A516259 Q30300277-32C3FAC8-BA4F-45D5-B05F-4184F135F850 Q33358887-3FA70B00-D58F-4694-8BBC-3C475D2D656F Q33574876-C0C9C3F4-73AD-4B20-B9F0-3232B90864CA Q33852990-EEB194EC-F070-4014-8C68-23C93968D8C5 Q34166571-29181706-BD3D-479B-BAB3-5EC35177F435 Q35577604-46737037-F794-4C50-9679-709CD1CA2366 Q35589449-2DE6EBAA-3CEF-4642-8AA2-0C4367E03D77 Q35769726-586DD8BA-6F48-4001-AEA2-F251809A3FFC Q35827532-F4CF489A-19A4-45AF-9160-6DAF6A384B83 Q35939076-1A63F539-8A45-43DB-83D8-1865588ECFE6 Q35984123-CA00A5FE-FAB0-4E55-A25C-6AE7551F578F Q36167100-9363D692-C1CD-4594-BF56-8C0AE0880569 Q36256005-955DBFCE-1E74-46ED-854B-EF78825F9E64 Q36289817-712CCAA2-2897-4FAB-8F5B-C5F7B198E583 Q36406527-5F481AD5-3142-4CEA-BF05-7115C01560DD Q36426385-4B6BECC9-C2C9-45BC-A20D-9D46F5C439DB Q36658984-3AA4835A-CD61-43A2-96D5-3E8214A444F3 Q36692411-5E56D53A-5A3E-4151-92FB-616D3387BDCF Q36916201-5F552998-54FC-406D-B878-EABA78CEF977 Q36966224-CCDF45FB-3A5C-4E44-A6C3-461EDD4A8327 Q37055921-1F8CD9A7-5E34-4425-A498-39E1760927CA Q37089231-47D0D927-D77D-4E1D-88AE-130B57BC27A1 Q37109198-98B7A8F5-F448-4F73-AB6A-A7D6EFD503E5 Q37442005-DF4F8DCB-C32B-4520-9A19-26FE0F4FAA90 Q38235447-35855EB2-0169-4052-9E79-C88C592CAFF5 Q38246584-89969E49-9382-41D2-B08A-D30850A2E14E Q38256162-CBE662AD-A47D-4B46-BCEE-DAC39519A7A9 Q38259275-0105C67F-3C38-4914-BDAD-4457E824D9BF Q38271442-B7CA97B3-3AA8-4DDE-A466-7DE30708BB42 Q38278145-43A75356-AD60-4511-A9E1-B9367F7F3D98 Q38296706-2CBB5273-793A-4916-9E2B-E3168EF282F2 Q38348057-948E3DBF-6AA0-4520-AA7D-B3B6AA9027B2 Q38503330-90E3776A-6BE6-46BC-9918-3B456841CC0B Q38542313-1DA3120A-44E8-49B2-B98F-75AD95FC9349 Q38542587-E9CA087B-C3C6-4887-9671-3D71D1F38D8C

P2860

Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3).

http://www.wikidata.org/entity/Q33999649

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Peanut oral immunotherapy resu ...... orkhead box protein 3 (FOXP3).

@ast

Peanut oral immunotherapy resu ...... orkhead box protein 3 (FOXP3).

@en

type

label

Peanut oral immunotherapy resu ...... orkhead box protein 3 (FOXP3).

@ast

Peanut oral immunotherapy resu ...... orkhead box protein 3 (FOXP3).

@en

prefLabel

Peanut oral immunotherapy resu ...... orkhead box protein 3 (FOXP3).

@ast

Peanut oral immunotherapy resu ...... orkhead box protein 3 (FOXP3).

@en

P1433

Q33999649-89DA8F54-7108-40A6-A1A4-F7A8690FE333

P1476

Q33999649-87D64539-0142-4DAE-A264-D904F5E3CCC4

P2093

Q33999649-24452C59-04DF-4FF7-84EF-B8D6A47129B9

Q33999649-25C64F30-83BB-42EA-882D-3619C489C845

Q33999649-3E33B437-79DD-4048-BA2C-4C7E02A35FC4

Q33999649-4052174A-9C12-472A-ACF7-017154031D9C

Q33999649-68D74E56-8636-4DC4-820A-7E5DDC367F1A

Q33999649-77F98853-3E7B-42BA-9919-254AF896E74F

Q33999649-8CF24E36-8E72-4061-ADD9-92BE8B72E49F

Q33999649-A01F7370-88A2-4D89-A753-0D0A76ABFD16

Q33999649-C6D26B0A-8E0B-4796-B367-5B45AC061AFA

Q33999649-DF415D25-9A45-4CC9-931C-5E96B35DAB85

P2860

Q33999649-02667ACF-8351-4774-ACE3-ADA6FFAD40BA

Q33999649-054A6DD1-34D3-4444-B864-12B4B3F44F48

Q33999649-05FFF4EC-BAF8-4BA7-93A3-601C1F272EF8

Q33999649-06593892-1E43-4C6D-A490-592791E57826

Q33999649-06B429AD-20F9-4DEC-B2F7-4A7B8E35FEB1

Q33999649-07E006C0-E070-4D8A-8ADB-9CAA52A03ED4

Q33999649-0BBF1EB9-6A04-4249-BA47-1A546F90F3FE

Q33999649-10F9570D-9B75-4EEF-A5B4-7A998BE8DF5F

Q33999649-13C867D3-3BD0-4D93-B595-B78B4D070BB8

Q33999649-14AC0728-B08D-4371-8D36-B710C856A5D5

P304

Q33999649-1A726C54-2C18-41E3-A213-D6EFCA6BFAEC

P31

Q33999649-149C00D1-0A36-43FA-849E-F78E55523A0A

P356

Q33999649-225C3CE9-0E09-425A-A68A-AD30580683EE

P407

Q33999649-1561B1CB-9D07-495B-B647-53CD2479C5FF

P433

Q33999649-AC0130AC-9F1A-4B71-81E6-00772E460034

P478

Q33999649-513F9CE9-A887-429B-9D32-AAEC74727289

P50

Q33999649-DDBC4436-3885-4177-8B99-3145B2B526E2

P577

Q33999649-BE2FF937-8479-4413-ACA1-114EC4E061D9

P698

Q33999649-69EF6178-9016-4DC2-8B79-405585982178

P921

Q33999649-5543D357-F8B2-4D27-A141-6614CB5228E1

P932

Q33999649-CCB3FB96-C9C6-4546-A7A2-EC840CB05F09

P356

J.JACI.2013.12.1037

P1433

The Journal of Allergy and Clinical Immunology

P1476

Peanut oral immunotherapy resu ...... orkhead box protein 3 (FOXP3).

@en

P2093

Aleena Syed

http://www.w3.org/2001/XMLSchema#string

Arunima Kohli

http://www.w3.org/2001/XMLSchema#string

Gerri O'Riordan

http://www.w3.org/2001/XMLSchema#string

Holden Maecker

http://www.w3.org/2001/XMLSchema#string

Jelena P Berglund

http://www.w3.org/2001/XMLSchema#string

Kari C Nadeau

http://www.w3.org/2001/XMLSchema#string

Marco A Garcia

http://www.w3.org/2001/XMLSchema#string

Mindy Tsai

http://www.w3.org/2001/XMLSchema#string

Robert Bucayu

http://www.w3.org/2001/XMLSchema#string

Satoru Ishida

http://www.w3.org/2001/XMLSchema#string

P2860

Control of regulatory T cell development by the transcription factor Foxp3

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

The basophil-specific ectoenzyme E-NPP3 (CD203c) as a marker for cell activation and allergy diagnosis

Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells

A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy

Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota

IDO expression by dendritic cells: tolerance and tryptophan catabolism

Regulatory T cells: mechanisms of differentiation and function

Specific immunotherapy and turning off the T cell: how does it work?

FOXP3 promoter demethylation reveals the committed Treg population in humans.

P304

500-510

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACI.2013.12.1037

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

133

http://www.w3.org/2001/XMLSchema#string

P50

Stephen J Galli

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24636474

http://www.w3.org/2001/XMLSchema#string

P921

P932

4121175

http://www.w3.org/2001/XMLSchema#string